118 related articles for article (PubMed ID: 25733690)
1. Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A.
Tang H; Singh S; Partyka K; Kletter D; Hsueh P; Yadav J; Ensink E; Bern M; Hostetter G; Hartman D; Huang Y; Brand RE; Haab BB
Mol Cell Proteomics; 2015 May; 14(5):1323-33. PubMed ID: 25733690
[TBL] [Abstract][Full Text] [Related]
2. Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer.
Kolben T; Müller L; Meister S; Keilmann L; Buschmann C; Trillsch F; Burges A; Czogalla B; Mitter S; Schmoeckel E; Corradini S; Mahner S; Jeschke U; Kessler M; Beyer S
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3323-3335. PubMed ID: 35729354
[TBL] [Abstract][Full Text] [Related]
3. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues.
McDowell CT; Klamer Z; Hall J; West CA; Wisniewski L; Powers TW; Angel PM; Mehta AS; Lewin DN; Haab BB; Drake RR
Mol Cell Proteomics; 2021; 20():100012. PubMed ID: 33581409
[TBL] [Abstract][Full Text] [Related]
4. Glycan array analysis of the antigen repertoire targeted by tumor-binding antibodies.
Gildersleeve JC; Wang B; Achilefu S; Tu Z; Xu M
Bioorg Med Chem Lett; 2012 Nov; 22(22):6839-43. PubMed ID: 23063402
[TBL] [Abstract][Full Text] [Related]
5. Prospects for developing an accurate diagnostic biomarker panel for low prevalence cancers.
Firpo MA; Boucher KM; Mulvihill SJ
Theor Biol Med Model; 2014 Aug; 11():34. PubMed ID: 25096727
[TBL] [Abstract][Full Text] [Related]
6. High-Throughput Analysis of Plasma Hybrid Markers for Early Detection of Cancers.
Rho JH; Lampe PD
Proteomes; 2014 Jan; 2(1):1-17. PubMed ID: 28250367
[TBL] [Abstract][Full Text] [Related]
7. Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer.
Wang CC; Huang YL; Ren CT; Lin CW; Hung JT; Yu JC; Yu AL; Wu CY; Wong CH
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11661-6. PubMed ID: 18689688
[TBL] [Abstract][Full Text] [Related]
8. Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer.
Kashiro A; Kobayashi M; Oh T; Miyamoto M; Atsumi J; Nagashima K; Takeuchi K; Nara S; Hijioka S; Morizane C; Kikuchi S; Kato S; Kato K; Ochiai H; Obata D; Shizume Y; Konishi H; Nomura Y; Matsuyama K; Xie C; Wong C; Huang Y; Jung G; Srivastava S; Kutsumi H; Honda K
J Gastroenterol; 2024 Mar; 59(3):263-278. PubMed ID: 38261000
[TBL] [Abstract][Full Text] [Related]
9. In situ recognition of cell-surface glycans and targeted imaging of cancer cells.
Xu XD; Cheng H; Chen WH; Cheng SX; Zhuo RX; Zhang XZ
Sci Rep; 2013; 3():2679. PubMed ID: 24042097
[TBL] [Abstract][Full Text] [Related]
10. Rat hepatocytes secrete free oligosaccharides.
Huang C; Seino J; Honda A; Fujihira H; Wu D; Okahara K; Kitazume S; Nakaya S; Kitajima K; Sato C; Suzuki T
J Biol Chem; 2024 Mar; 300(3):105712. PubMed ID: 38309509
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance related to aberrant glycosylation in colorectal cancer.
Very N; Lefebvre T; El Yazidi-Belkoura I
Oncotarget; 2018 Jan; 9(1):1380-1402. PubMed ID: 29416702
[TBL] [Abstract][Full Text] [Related]
12. A blood-based metabolomic signature predictive of risk for pancreatic cancer.
Irajizad E; Kenney A; Tang T; Vykoukal J; Wu R; Murage E; Dennison JB; Sans M; Long JP; Loftus M; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger JM; Maitra A; Do KA; Yu B; Wolpin BM; Hanash S; Fahrmann JF
Cell Rep Med; 2023 Sep; 4(9):101194. PubMed ID: 37729870
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of glycans containing 3' fucose in a subset of pancreatic cancers uncovered using fusion-tagged lectins.
Singh S; Pal K; Yadav J; Tang H; Partyka K; Kletter D; Hsueh P; Ensink E; Kc B; Hostetter G; Xu HE; Bern M; Smith DF; Mehta AS; Brand R; Melcher K; Haab BB
J Proteome Res; 2015 Jun; 14(6):2594-605. PubMed ID: 25938165
[TBL] [Abstract][Full Text] [Related]
14. Glycans related to the CA19-9 antigen are elevated in distinct subsets of pancreatic cancers and improve diagnostic accuracy over CA19-9.
Tang H; Partyka K; Hsueh P; Sinha JY; Kletter D; Zeh H; Huang Y; Brand RE; Haab BB
Cell Mol Gastroenterol Hepatol; 2016 Feb; 2(2):201-221.e15. PubMed ID: 26998508
[TBL] [Abstract][Full Text] [Related]
15. Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer.
Pettazzoni P; Viale A; Shah P; Carugo A; Ying H; Wang H; Genovese G; Seth S; Minelli R; Green T; Huang-Hobbs E; Corti D; Sanchez N; Nezi L; Marchesini M; Kapoor A; Yao W; Francesco ME; Petrocchi A; Deem AK; Scott K; Colla S; Mills GB; Fleming JB; Heffernan TP; Jones P; Toniatti C; DePinho RA; Draetta GF
Cancer Res; 2015 Mar; 75(6):1091-101. PubMed ID: 25736685
[TBL] [Abstract][Full Text] [Related]
16. Segment and fit thresholding: a new method for image analysis applied to microarray and immunofluorescence data.
Ensink E; Sinha J; Sinha A; Tang H; Calderone HM; Hostetter G; Winter J; Cherba D; Brand RE; Allen PJ; Sempere LF; Haab BB
Anal Chem; 2015 Oct; 87(19):9715-21. PubMed ID: 26339978
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal Antibodies Targeting LecLex-Related Glycans with Potent Antitumor Activity.
Chua JX; Vankemmelbeke M; McIntosh RS; Clarke PA; Moss R; Parsons T; Spendlove I; Zaitoun AM; Madhusudan S; Durrant LG
Clin Cancer Res; 2015 Jul; 21(13):2963-74. PubMed ID: 25779947
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells found in patients with localized and advanced pancreatic cancer.
Kulemann B; Pitman MB; Liss AS; Valsangkar N; Fernández-Del Castillo C; Lillemoe KD; Hoeppner J; Mino-Kenudson M; Warshaw AL; Thayer SP
Pancreas; 2015 May; 44(4):547-50. PubMed ID: 25822154
[TBL] [Abstract][Full Text] [Related]
19. Proteomics analysis of bodily fluids in pancreatic cancer.
Pan S; Brentnall TA; Chen R
Proteomics; 2015 Aug; 15(15):2705-15. PubMed ID: 25780901
[TBL] [Abstract][Full Text] [Related]
20. Development of lung adenocarcinomas with exclusive dependence on oncogene fusions.
Saito M; Shimada Y; Shiraishi K; Sakamoto H; Tsuta K; Totsuka H; Chiku S; Ichikawa H; Kato M; Watanabe S; Yoshida T; Yokota J; Kohno T
Cancer Res; 2015 Jun; 75(11):2264-71. PubMed ID: 25855381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
